Atypical manifestations of Wilson — Konovalov disease (clinical case)

December 21, 2021
978
Resume

Wilson’s disease is a rare genetic disorder that should be considered in the differential diagnosis if the patient has neurological, psychiatric and/or hepatic manifestations. The most common manifestations of liver damage in Wilson’s disease are slowly progressive liver failure with cirrhosis, ascites, varicose veins of the esophagus, splenomegaly. Symptoms of nervous system damage are often nonspecific and include behavioral, personality, and cognitive impairment, less often tremor, dysarthria, and dysphonia. The article considers modern aspects of etiology, pathogenesis, clinic, diagnosis of Wilson’s disease, as well as our own clinical observation of the case of newly detected hepatolenticular degeneration in a 29-year-old patient. This clinical case is interesting for the lesion of the brain stem (bridge) on the background of a typical lesion of the basal ganglia.

References

  • 1. Scheiber I.F., Brůha R., Dušek P. (2017) Pathogenesis of Wilson disease. Handb. Clin. Neurol., 142: 43–55. doi: 10.1016/B978-0-444-63625-6.00005-7.
  • 2. Stapelbroek J.M., Bollen C.W., van Amstel J.K. et al. (2004) The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J. Hepatol., 41(5): 758–763. doi: 10.1016/j.jhep.2004.07.017.
  • 3. Pfeiffer R.F. (2016) Wilson Disease. Continuum (Minneap. Minn.), 22(4 Movement Disorders): 1246–1261. doi: 10.1212/CON.0000000000000350.
  • 4. http://www.dec.gov.ua/wp-content/uploads/2019/11/2016_769_ykpmd_vils.pdf.
  • 5. Członkowska A., Litwin T., Chabik G. (2017) Wilson disease: neurologic features. Handb. Clin. Neurol., 142: 101–119. doi: 10.1016/B978-0-444-63625-6.00010-0.
  • 6. EASL (2012) Clinical Practice Guidelines: Wilson’s disease. J. Hepatol., 56: 671–685.
  • 7. Taly A.B., Meenakshi-Sundaram S., Sinha S. et al. (2007) Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore), 86(2): 112–121. doi: 10.1097/MD.0b013e318045a00e.
  • 8. Mahjoub F., Fereiduni R., Jahanzad I. et al. (2012) Atomic Absorption Spectrometry in Wilson’s Disease and Its Comparison with Other Laboratory Tests and Paraclinical Findings. Iran J. Pediatr., 22(1): 52–56. PMID: 23056859.
  • 9. Hermann W. (2019) Classification and differential diagnosis of Wilson’s disease. Ann. Transl. Med., 7(Suppl. 2): S63. doi: 10.21037/atm.2019.02.07.
  • 10. Schilsky M.L. (2017) Wilson Disease: Diagnosis, Treatment, and Follow-up. Clin. Liver Dis., 21(4): 755–767. doi: 10.1016/j.cld.2017.06.011.
  • 11. search.ligazakon.ua/l_doc2.nsf/link1/MOZ26291.html.
  • 12. Brewer G.J., Terry C.A., Aisen A.M., Hill G.M. (1987) Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch. Neurol., 44(5): 490–493. doi: 10.1001/archneur.1987.00520170020016.